42 related articles for article (PubMed ID: 9884321)
1. In vitro metabolism of the M1-muscarinic agonist 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine by human hepatic cytochromes P-450 determined at pH 7.4 and 8.5.
Jensen KG; Dalgaard L
Drug Metab Dispos; 1999 Jan; 27(1):125-32. PubMed ID: 9884321
[TBL] [Abstract][Full Text] [Related]
2. Metabolites of [(14)C]-5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3, 6-tetrahydropyridine in mice, rats, dogs, and humans.
Christensen EB; Andersen JB; Pedersen H; Jensen KG; Dalgaard L
Drug Metab Dispos; 1999 Nov; 27(11):1341-9. PubMed ID: 10534320
[TBL] [Abstract][Full Text] [Related]
3. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Subrahmanyam V; Renwick AB; Walters DG; Young PJ; Price RJ; Tonelli AP; Lake BG
Drug Metab Dispos; 2001 Aug; 29(8):1146-55. PubMed ID: 11454734
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
[TBL] [Abstract][Full Text] [Related]
5. Flavin-containing monooxygenase-mediated N-oxidation of the M(1)-muscarinic agonist xanomeline.
Ring BJ; Wrighton SA; Aldridge SL; Hansen K; Haehner B; Shipley LA
Drug Metab Dispos; 1999 Oct; 27(10):1099-103. PubMed ID: 10497134
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytochrome P-450 isoform(s) responsible for the metabolism of pimobendan in human liver microsomes.
Kuriya Si; Ohmori S; Hino M; Ishii I; Nakamura H; Senda C; Igarashi T; Kiuchi M; Kitada M
Drug Metab Dispos; 2000 Jan; 28(1):73-8. PubMed ID: 10611143
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
Fang J; McKay G; Song J; Remillrd A; Li X; Midha K
Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
[TBL] [Abstract][Full Text] [Related]
9. Roles of FMO and CYP450 in the metabolism in human liver microsomes of S-methyl-N,N-diethyldithiocarbamate, a disulfiram metabolite.
Pike MG; Martin YN; Mays DC; Benson LM; Naylor S; Lipsky JJ
Alcohol Clin Exp Res; 1999 Jul; 23(7):1173-9. PubMed ID: 10443982
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes.
Wynalda MA; Hauer MJ; Wienkers LC
Drug Metab Dispos; 2000 Sep; 28(9):1014-7. PubMed ID: 10950842
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
12. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
16. Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004.
Hvenegaard MG; Bang-Andersen B; Pedersen H; Jørgensen M; Püschl A; Dalgaard L
Drug Metab Dispos; 2012 Jul; 40(7):1357-65. PubMed ID: 22496396
[TBL] [Abstract][Full Text] [Related]
17. In vitro identification of the human cytochrome p450 enzymes involved in the oxidative metabolism of loxapine.
Luo JP; Vashishtha SC; Hawes EM; McKay G; Midha KK; Fang J
Biopharm Drug Dispos; 2011 Oct; 32(7):398-407. PubMed ID: 21826677
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of CJ-036878, N-(3-phenethoxybenzyl)-4-hydroxybenzamide, in liver microsomes and recombinant cytochrome P450 enzymes: metabolite identification by LC-UV/MS(n) and (1)H-NMR.
Nishida H; Hirai H; Emoto C; Iwasaki K
Xenobiotica; 2007 Dec; 37(12):1394-407. PubMed ID: 18033636
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin.
Parte P; Kupfer D
Drug Metab Dispos; 2005 Oct; 33(10):1446-52. PubMed ID: 15987777
[TBL] [Abstract][Full Text] [Related]
20. Species differential stereoselective oxidation of a methylsulfide metabolite of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor dual agonist.
Karanam BV; Welch CJ; Reddy VG; Chilenski J; Biba M; Vincent S
Drug Metab Dispos; 2004 Oct; 32(10):1061-8. PubMed ID: 15229170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
